Faecal microbial transfer and complex carbohydrates mediate protection against COPD
Kurtis F Budden1, Shakti D Shukla1, Kate L Bowerman2
1Priority Research Centre for Healthy Lungs and Immune Health Research Program, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia.
Gut
|February 8, 2024
Summary
The gut microbiome plays a role in chronic obstructive pulmonary disease (COPD) development. Modulating the gut microbiota with complex carbohydrates can improve COPD symptoms and lung function.
Area of Science:
- Microbiology
- Pulmonology
- Gastroenterology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality, with pathogenesis poorly understood, hindering effective treatments.
- The gut-lung axis suggests a link between the gastrointestinal microbiome and chronic lung diseases, but its specific role in COPD is unclear.
Purpose of the Study:
- To investigate the role of the gut microbiome in cigarette smoke (CS)-induced COPD.
- To explore the therapeutic potential of targeting the gut microbiome in COPD.
Main Methods:
- Utilized a mouse model of CS-induced COPD and fecal microbial transfer (FMT).
- Employed metagenomics, proteomics, and metabolomics to characterize the gut microbiota.
- Assessed complex carbohydrate interventions in mice and human COPD patients.
Main Results:
- Fecal microbial transfer ameliorated COPD features, including inflammation, lung damage, and impaired lung function.
- Gut microbiota alterations were linked to specific bacterial families (Muribaculaceae, Desulfovibrionaceae, Lachnospiraceae).
- Complex carbohydrate supplementation improved COPD outcomes in both mice and human patients.
Conclusions:
- The gut microbiome is a significant contributor to COPD pathogenesis.
- Targeting the gut microbiome, particularly with complex carbohydrates, offers a potential therapeutic strategy for COPD.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Defense Mechanism Against Infection
6.5K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
6.5K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
What is Monogastric Digestion?
71.2K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K


